NM_004958.4(MTOR):c.976C>T (p.Gln326Ter) AND not provided

Germline classification:: Uncertain significance (1 submission)
Last evaluated:: Nov 23, 2023
Review status:: 1 star out of maximum of 4 stars
criteria provided, single submitter

Somatic classification of clinical impact:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Somatic classification of oncogenicity:: None
Review status:: (0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided

Record status:: current
Accession:: RCV003543796.2

Allele description [Variation Report for NM_004958.4(MTOR):c.976C>T (p.Gln326Ter)]

NM_004958.4(MTOR):c.976C>T (p.Gln326Ter)

Gene:

MTOR:mechanistic target of rapamycin kinase [Gene - OMIM - HGNC]

Variant type:

single nucleotide variant

Cytogenetic location:

1p36.22

Genomic location:

Preferred name:

NM_004958.4(MTOR):c.976C>T (p.Gln326Ter)

HGVS:

NC_000001.11:g.11247959G>A
NG_033239.1:g.19593C>T
NM_001386500.1:c.976C>T
NM_001386501.1:c.-164C>T
NM_004958.4:c.976C>TMANE SELECT
NP_001373429.1:p.Gln326Ter
NP_004949.1:p.Gln326Ter
NP_004949.1:p.Gln326Ter
LRG_734t1:c.976C>T
LRG_734:g.19593C>T
LRG_734p1:p.Gln326Ter
NC_000001.10:g.11308016G>A
NM_004958.3:c.976C>T

Protein change:

Q326*

Molecular consequence:

NM_001386501.1:c.-164C>T - 5 prime UTR variant - [Sequence Ontology: SO:0001623]
NM_001386500.1:c.976C>T - nonsense - [Sequence Ontology: SO:0001587]
NM_004958.4:c.976C>T - nonsense - [Sequence Ontology: SO:0001587]

Condition(s)

Synonyms:: none provided
Identifiers:: MedGen: C3661900

Recent activity

Clear Turn Off Turn On

MIR432 [Macaca mulatta]
MIR432 [Macaca mulatta]
Gene ID:100315262

Gene
ATP6AP1 ATPase H+ transporting accessory protein 1 [Bos taurus]
ATP6AP1 ATPase H+ transporting accessory protein 1 [Bos taurus]
Gene ID:327687

Gene

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

Help

Submission Accession	Submitter	Review Status (Assertion method)	Clinical Significance (Last evaluated)	Origin	Method	Citations
SCV004253475	Labcorp Genetics (formerly Invitae), Labcorp	criteria provided, single submitter (Invitae Variant Classification Sherloc (09022015))	Uncertain significance (Nov 23, 2023)	germline	clinical testing	PubMed (1) [See all records that cite this PMID]

Submission Accession

Submitter

Review Status
(Assertion method)

Clinical Significance
(Last evaluated)

Origin

Method

Citations

SCV004253475

Labcorp Genetics (formerly Invitae), Labcorp

criteria provided, single submitter

(Invitae Variant Classification Sherloc (09022015))

Uncertain significance
(Nov 23, 2023)

germline

clinical testing

PubMed (1)
[See all records that cite this PMID]

Help

Summary from all submissions

Ethnicity	Origin	Affected	Individuals	Families	Chromosomes tested	Number Tested	Family history	Method
not provided	germline	unknown	not provided	not provided	not provided	not provided	not provided	clinical testing

Citations

PubMed

Sherloc: a comprehensive refinement of the ACMG-AMP variant classification criteria.

Nykamp K, Anderson M, Powers M, Garcia J, Herrera B, Ho YY, Kobayashi Y, Patil N, Thusberg J, Westbrook M; Invitae Clinical Genomics Group., Topper S.

Genet Med. 2017 Oct;19(10):1105-1117. doi: 10.1038/gim.2017.37. Epub 2017 May 11. Erratum in: Genet Med. 2020 Jan;22(1):240. doi: 10.1038/s41436-019-0624-9.

PubMed [citation]

PMID:: 28492532
PMCID:: PMC5632818

Details of each submission

From Labcorp Genetics (formerly Invitae), Labcorp, SCV004253475.1

#	Ethnicity	Individuals	Chromosomes Tested	Family History	Method	Citations
1	not provided	not provided	not provided	not provided	clinical testing	PubMed (1)

Description

This sequence change creates a premature translational stop signal (p.Gln326*) in the MTOR gene. It is expected to result in an absent or disrupted protein product. However, the current clinical and genetic evidence is not sufficient to establish whether loss-of-function variants in MTOR cause disease. This variant is not present in population databases (gnomAD no frequency). This variant has not been reported in the literature in individuals affected with MTOR-related conditions. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance.

#	Sample				Method		Observation
#	Origin	Affected	Number tested	Tissue	Purpose	Method	Individuals	Allele frequency	Families	Co-occurrences
1	germline	unknown	not provided	not provided	not provided		not provided	not provided	not provided	not provided

Last Updated: Sep 29, 2024

ClinVar

Relating variation to medicine